Data as of Q4 2025 (Dec 31, 2025)

TSFG, LLC

โ€ขCIK: 1800513โ€ขFiling: Q4 2025

**TSFG, LLC** manages $669M across a diversified portfolio of 800 positions. The fund exhibits significant concentration in technology and market-linked assets, notably holding DYNF at $50.2M and SPYV at $38.0M. Key allocations also include IWF ($37.5M), IEMG ($30.9M), and ABBV ($28.5M), suggesting a tactical blend of sector bets and broad market exposure. This structure indicates an active, large-cap oriented mandate with substantial conviction in select growth areas.

Total AUM
$669.5M
QoQ Performance
+6.3%
Positions
641
Top 10 Concentration
41.9%
Latest Filing
Q4 2025

Top Holdings Allocation

DYNF
SPYV
IWF
DYNF7.5%
SPYV5.7%
IWF5.6%
IEMG4.6%
ABBV4.3%
VOO3.7%
VTI2.6%
AAPL2.4%

๐Ÿ“ˆ Biggest Buys

DYNF
ISHARES U S
+37.1%
7.5% of portfolio
IEMG
ISHARES CORE
+64.6%
4.6% of portfolio
RDVY
FIRST TRUST
NEW
1.3% of portfolio
BAI
ISHARES A I
+68.8%
2.0% of portfolio
HDEF
XTRACKERS
+56.9%
2.2% of portfolio

๐Ÿ“‰ Biggest Sells

QUAL
ISHARES MSCI
-46.6%
1.2% of portfolio
JQUA
JPMORGAN US
-51.1%
0.7% of portfolio
SPHQ
INVESCO S&P
-41.9%
1.0% of portfolio
HFXI
NYLI FTSE
-89.4%
0.1% of portfolio
IQDG
WISDOMTREE INTL
-85.2%
0.1% of portfolio

Sector Breakdown

Other75.5%
Healthcare7.1%
Technology6.7%
ETF6.0%
Consumer3.0%
Financial0.8%
Communication0.3%
Energy0.3%

๐Ÿšช Exited Positionssold since Q3 2025

FLXR
TCW FLEXIBLE
SOLD
$2.6M
VCIT
VANGUARD INTERMEDIATE
SOLD
$542.0K
STIP
ISHARES 0-5
SOLD
$458.0K
BMNR
BITMINE IMMERSION
SOLD
$286.0K
TAK
TAKEDA PHARMACEUTICAL
SOLD
$236.0K
+614 more exited positions

Changes from Q3 2025

NEW3 new positions
โ†‘99 increased
โ†“73 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023